Vaderis Therapeutics AG is a clinical stage biotech focussing on treatment of rare diseases caused by vascular malformations.  The company was founded in 2019 in Basel, Switzerland, and closed a Series A investment of CHF18.1Mio in 2020.

 

 

Location

Bäumleingasse 18, 4051 Basel, Switzerland

Facts & figures
  • Year of foundation

    2019

  • Number of employees in Switzerland

    1-9

Key business